Anticipating the challenges of zika virus and the incidence of Guillain-Barré syndrome

JAMA Neurology

Volumn 73, Issue 8, 2016, Pages 905-906

  Gold, Carl A ^a   Andrew Josephson, S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE SEVERITY; EMERGENCY HEALTH SERVICE; GUILLAIN BARRE SYNDROME; HUMAN; INCIDENCE; INFECTION RISK; MEDICAL EDUCATION; NOTE; PATIENT MONITORING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; UNITED STATES; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION; ZIKA FEVER; ZIKA VIRUS; GLOBAL HEALTH; PATHOGENICITY;

GLOBAL HEALTH; GUILLAIN-BARRE SYNDROME; HUMANS; INCIDENCE; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 84981214269     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2016.1268     Document Type: Note

References (7)

1. Yuki N, Hartung H-P. Guillain-Barré syndrome. N Engl J Med. 2012;366(24):2294-2304.
2. World Health Organization. Identification and management of Guillain-Barré syndrome in the context of Zika virus. http://www.who.int/csr/resources/publications/zika/guillain-barre-syndrome/en/. Published February 25, 2016. Accessed March 4, 2016.
3. Cao-Lormeau VM, Blake A, Mons S, et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387(10027): 1531-1539.
4. Bogoch II, Brady OJ, Kraemer MUG, et al. Anticipating the international spread of Zika virus from Brazil. Lancet. 2016;387(10016):335-336.
5. Ajao A, Nystrom SV, Koonin LM, et al. Assessing the capacity of the US health care system to use additional mechanical ventilators during a large-scale public health emergency. Disaster Med Public Health Prep. 2015;9(6):634-641.
6. Hughes RAC, Wijdicks EFM, Barohn R, et al; Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: immunotherapy for Guillain-Barré syndrome. report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2003; 61(6):736-740.
7. Orange JS, Ochs HD, Cunningham-Rundles C. Prioritization of evidence-based indications for intravenous immunoglobulin. J Clin Immunol. 2013; 33(6):1033-1036.